col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

The Royal Society of Chemistry: RSC Advances
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―16 Bis-indolylation of aldehydes and ketones using silica-supported FeCl3: molecular docking studies of bisindoles by targeting SARS-CoV-2 main protease binding sites Barnali Deb, Sudhan Debnath, Ankita Chakraborty, Swapan Majumdar
2 [GO] 2021―Sep―09 The SARS-CoV-2 B.1.618 variant slightly alters the spike RBD-ACE2 binding affinity and is an antibody escaping variant: a computational structural perspective Abbas Khan, Jianjun Gui, Waqar Ahmad, Inamul Haq, Marukh Shahid, Awais Ahmed Khan, et al. (+10)
3 [GO] 2021―Sep―02 Comparative assessment of RNA-dependent RNA polymerase (RdRp) inhibitors under clinical trials to control SARS-CoV2 using rigorous computational workflow Dweipayan Goswami
4 [GO] 2021―Aug―03 In silico study of the inhibition of SARS-COV-2 viral cell entry by neem tree extracts Daniel M. Shadrack, Said A. H. Vuai, Mtabazi G. Sahini, Isaac Onoka
5 [GO] 2021―Aug―02 Nanomaterial-based drug delivery systems as promising carriers for patients with COVID-19 M. Abd Elkodous, S. O. Olojede, Mahmoud Morsi, Gharieb S. El-Sayyad
6 [GO] 2021―Jul―26 Detection of SARS-CoV-2 and its S and N proteins using surface enhanced Raman spectroscopy John Eder Sanchez, Sierra A. Jaramillo, Erik Settles, J. Jesus Velazquez Salazar, Alexander Lehr, Javier Gonzalez, et al. (+9)
7 [GO] 2021―Jul―02 Drug repurposing and computational modeling for discovery of inhibitors of the main protease (Mpro) of SARS-CoV-2 José Rogério A. Silva, Hendrik G. Kruger, Fábio A. Molfetta
8 [GO] 2021―Jun―24 In silico study of natural compounds from sesame against COVID-19 by targeting Mpro, PLpro and RdRp Ahmed E. Allam, Yhiya Amen, Ahmed Ashour, Hamdy K. Assaf, Heba Ali Hassan, Islam M. Abdel-Rahman, et al. (+2)
9 [GO] 2021―Jun―23 Potential inhibitors for SARS-CoV-2 Mpro from marine compounds Nguyen Minh Tam, Minh Quan Pham, Huy Truong Nguyen, Nam Dao Hong, Nguyen Khoa Hien, Duong Tuan Quang, et al. (+2)
10 [GO] 2021―Jun―09 A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2 Kannan Damodharan, Gandarvakottai Senthilkumar Arumugam, Suresh Ganesan, Mukesh Doble, Sathiah Thennarasu
11 [GO] 2021―Jun―04 Two novel oxetane containing lignans and a new megastigmane from Paronychia arabica and in silico analysis of them as prospective SARS-CoV-2 inhibitors Abdelsamed I. Elshamy, Tarik A. Mohamed, Mahmoud A. A. Ibrahim, Mohamed A. M. Atia, Tatsuro Yoneyama, Akemi Umeyama, Mohamed-Elamir F. Hegazy
12 [GO] 2021―May―28 3D printed chitosan/polycaprolactone scaffold for lung tissue engineering: hope to be useful for COVID-19 studies Farnoush Sadat Rezaei, Ayeh Khorshidian, Farzaneh Mahmoudi Beram, Atefeh Derakhshani, Javad Esmaeili, Aboulfazl Barati
13 [GO] 2021―May―19 Immunoinformatics-guided design of a multi-epitope vaccine based on the structural proteins of severe acute respiratory syndrome coronavirus 2 Ahmad J. Obaidullah, Mohammed M. Alanazi, Nawaf A. Alsaif, Hussam Albassam, Abdulrahman A. Almehizia, Ali M. Alqahtani, et al. (+3)
14 [GO] 2021―May―12 A review on potential of natural products in the management of COVID-19 Rudra Chakravarti, Rajveer Singh, Arijit Ghosh, Dhritiman Dey, Priyanka Sharma, Ravichandiran Velayutham, et al. (+2)
15 [GO] 2021―May―12 Computational estimation of potential inhibitors from known drugs against the main protease of SARS-CoV-2 Nguyen Minh Tam, Minh Quan Pham, Nguyen Xuan Ha, Pham Cam Nam, Huong Thi Thu Phung
16 [GO] 2021―May―10 Single point mutations can potentially enhance infectivity of SARS-CoV-2 revealed by in silico affinity maturation and SPR assay Ting Xue, Weikun Wu, Ning Guo, Chengyong Wu, Jian Huang, Lipeng Lai, et al. (+4)
17 [GO] 2021―May―05 Latin American databases of natural products: biodiversity and drug discovery against SARS-CoV-2 Marvin J. Núñez, Bárbara I. Díaz-Eufracio, José L. Medina-Franco, Dionisio A. Olmedo
18 [GO] 2021―Apr―12 Flavonoids of Salvadora persica L. (meswak) and its liposomal formulation as a potential inhibitor of SARS-CoV-2 Asmaa I. Owis, Marwa S. El-Hawary, Dalia El Amir, Hesham Refaat, Eman Alaaeldin, Omar M. Aly, et al. (+2)
19 [GO] 2021―Apr―07 Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach Jubie Selvaraj, Shyam Sundar P, Logesh Rajan, Divakar Selvaraj, Dhanabal Palanisamy, Krishnan Namboori PK, Suresh Kumar Mohankumar
20 [GO] 2021―Mar―25 The inhibition of Mpro, the primary protease of COVID-19, by Poria cocos and its active compounds: a network pharmacology and molecular docking study Zhimin Wu, Xiaoxue Chen, Weiju Ni, Danshui Zhou, Shanshan Chai, Weile Ye, et al. (+4)
21 [GO] 2021―Mar―24 A phytochemical-based medication search for the SARS-CoV-2 infection by molecular docking models towards spike glycoproteins and main proteases Anju Choorakottayil Pushkaran, Prajeesh Nath EN, Anu R. Melge, Rammanohar Puthiyedath, C. Gopi Mohan
22 [GO] 2021―Mar―09 Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study Ayman Abo Elmaaty, Radwan Alnajjar, Mohammed I. A. Hamed, Muhammad Khattab, Mohamed M. Khalifa, Ahmed A. Al-Karmalawy
23 [GO] 2021―Feb―25 Insight into the origin of SARS-CoV-2 through structural analysis of receptor recognition: a molecular simulation study Jixue Sun, Meijiang Liu, Na Yang
24 [GO] 2021―Feb―08 A comprehensive review on antimicrobial face masks: an emerging weapon in fighting pandemics Gayathri Pullangott, Uthradevi Kannan, Gayathri S., Degala Venkata Kiran, Shihabudheen M. Maliyekkal
25 [GO] 2021―Feb―02 Carbon nanotubes for rapid capturing of SARS-COV-2 virus: revealing a mechanistic aspect of binding based on computational studies Shivkumar Patel, Amit Kumar Srivastav, Sanjeev K. Gupta, Umesh Kumar, S. K. Mahapatra, P. N. Gajjar, I. Banerjee
26 [GO] 2021―Jan―27 Combination of system biology to probe the anti-viral activity of andrographolide and its derivative against COVID-19 Pukar Khanal, Yadu Nandan Dey, Rajesh Patil, Rupesh Chikhale, Manish M. Wanjari, Shailendra S. Gurav, et al. (+3)
27 [GO] 2021―Jan―22 Ligand-based design, molecular dynamics and ADMET studies of suggested SARS-CoV-2 Mpro inhibitors Nada M. Mohamed, Eslam M. H. Ali, Asmaa M. AboulMagd
28 [GO] 2021―Jan―19 In silico design of peptides with binding to the receptor binding domain (RBD) of the SARS-CoV-2 and their utility in bio-sensor development for SARS-CoV-2 detection Yogesh Badhe, Rakesh Gupta, Beena Rai
29 [GO] 2021―Jan―15 Correction: The inactivation mechanism of chemical disinfection against SARS-CoV-2: from MD and DFT perspectives Chunjian Tan, Chenshan Gao, Quan Zhou, Willem Van Driel, Huaiyu Ye, Guoqi Zhang
30 [GO] 2021―Jan―14 Interaction analyses of SARS-CoV-2 spike protein based on fragment molecular orbital calculations Kazuki Akisawa, Ryo Hatada, Koji Okuwaki, Yuji Mochizuki, Kaori Fukuzawa, Yuto Komeiji, Shigenori Tanaka
31 [GO] 2021―Jan―13 Binding of inhibitors to the monomeric and dimeric SARS-CoV-2 Mpro Nguyen Minh Tam, Pham Cam Nam, Duong Tuan Quang, Nguyen Thanh Tung, Van V. Vu, Son Tung Ngo
32 [GO] 2021―Jan―13 Inhibitory activity of quercetin, its metabolite, and standard antiviral drugs towards enzymes essential for SARS-CoV-2: the role of acid-base equilibria Žiko B. Milanović, Marko R. Antonijević, Ana D. Amić, Edina H. Avdović, Dušan S. Dimić, Dejan A. Milenković, Zoran S. Marković
33 [GO] 2021―Jan―04 Immune response and possible therapeutics in COVID-19 Anindya Dutta, Ananya Roy, Laboni Roy, Samit Chattopadhyay, Subhrangsu Chatterjee
34 [GO] 2020―Dec―14 Interpretation of SARS-CoV-2 behaviour on different substrates and denaturation of virions using ethanol: an atomic force microscopy study Umit Celik, Kubra Celik, Suleyman Celik, Hasan Abayli, Kezban Can Sahna, Şükrü Tonbak, et al. (+2)
35 [GO] 2020―Dec―07 1-Phenyl-N-(benzothiazol-2-yl)methanimine derivatives as Middle East respiratory syndrome coronavirus inhibitors Min-Qi Hu, Heng Li, Ying Lin, Ying Zhang, Jie Tang, Jian-Ping Zuo, et al. (+4)
36 [GO] 2020―Nov―26 In silico identification of SARS-CoV-2 spike (S) protein-ACE2 complex inhibitors from eight Tecoma species and cultivars analyzed by LC-MS Seham S. El Hawary, Amira R. Khattab, Hanan S. Marzouk, Amira S. El Senousy, Mariam G. A. Alex, Omar M. Aly, et al. (+2)
37 [GO] 2020―Nov―25 Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro Vishal M. Balaramnavar, Khurshid Ahmad, Mohd Saeed, Irfan Ahmad, Mehnaz Kamal, Talha Jawaid
38 [GO] 2020―Nov―10 Accelerating the repurposing of FDA-approved drugs against coronavirus disease-19 (COVID-19) Simona De Vita, Maria Giovanna Chini, Gianluigi Lauro, Giuseppe Bifulco
39 [GO] 2020―Nov―09 Assessing potential inhibitors of SARS-CoV-2 main protease from available drugs using free energy perturbation simulations Son Tung Ngo, Hung Minh Nguyen, Le Thi Thuy Huong, Pham Minh Quan, Vi Khanh Truong, Nguyen Thanh Tung, Van V. Vu
40 [GO] 2020―Nov―06 The inactivation mechanism of chemical disinfection against SARS-CoV-2: from MD and DFT perspectives Chunjian Tan, Chenshan Gao, Quan Zhou, Willem Van Driel, Huaiyu Ye, Guoqi Zhang
41 [GO] 2020―Nov―04 Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease Vladimir Frecer, Stanislav Miertus
42 [GO] 2020―Nov―04 Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro Vishal M. Balaramnavar, Khurshid Ahmad, Mohd Saeed, Irfan Ahmad, Mehnaz Kamal, Talaha Jawed
43 [GO] 2020―Nov―02 Amino acid interacting network in the receptor-binding domain of SARS-CoV-2 spike protein Puja Adhikari, Wai-Yim Ching
44 [GO] 2020―Nov―01 ACE2 as a potential therapeutic target for pandemic COVID-19 Bhaswati Chatterjee, Suman S. Thakur
45 [GO] 2020―Oct―15 Anti-inflammatory, antiallergic and COVID-19 protease inhibitory activities of phytochemicals from the Jordanian hawksbeard: identification, structure-activity relationships, molecular modeling and impact on its folk medicinal uses Sherif S. Ebada, Nariman A. Al-Jawabri, Fadia S. Youssef, Dina H. El-Kashef, Tim-Oliver Knedel, Amgad Albohy, et al. (+9)
46 [GO] 2020―Oct―13 Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study Malvi Surti, Mitesh Patel, Mohd Adnan, Afrasim Moin, Syed Amir Ashraf, Arif Jamal Siddiqui, et al. (+3)
47 [GO] 2020―Sep―30 Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework Neeraj Kumar, Damini Sood, Ramesh Chandra
48 [GO] 2020―Sep―23 Diagnostic technologies for COVID-19: a review Qi Chen, Zhenyun He, Fujing Mao, Hua Pei, Hongmei Cao, Xing Liu
49 [GO] 2020―Sep―23 Several coumarin derivatives and their Pd(ii) complexes as potential inhibitors of the main protease of SARS-CoV-2, an in silico approach Dejan A. Milenković, Dušan S. Dimić, Edina H. Avdović, Zoran S. Marković
50 [GO] 2020―Sep―18 Carotane sesquiterpenes from Ferula vesceritensis: in silico analysis as SARS-CoV-2 binding inhibitors Tarik A. Mohamed, Abdelsamed I. Elshamy, Mahmoud A. A. Ibrahim, Ammar Zellagui, Mahmoud F. Moustafa, Alaa H. M. Abdelrahman, et al. (+3)
51 [GO] 2020―Sep―15 Quinazoline-Schiff base conjugates: in silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins Mostafa A. Mansour, Asmaa M. AboulMagd, Hamdy M. Abdel-Rahman
52 [GO] 2020―Sep―15 Automated multiplex nucleic acid tests for rapid detection of SARS-CoV-2, influenza A and B infection with direct reverse-transcription quantitative PCR (dirRT-qPCR) assay in a centrifugal microfluidic platform Minghui Ji, Yun Xia, Jacky Fong-Chuen Loo, Lang Li, Ho-Pui Ho, Jianan He, Dayong Gu
53 [GO] 2020―Sep―04 Development of a tablet PC-based portable device for colorimetric determination of assays including COVID-19 and other pathogenic microorganisms Woo Sik Yoo, Hyung Soo Han, Jung Gon Kim, Kitaek Kang, Hyo-Sung Jeon, Jin-Young Moon, Hyeonmi Park
54 [GO] 2020―Aug―28 Inhibition of SARS-CoV-2 main protease by phenolic compounds from Manilkara hexandra (Roxb.) Dubard assisted by metabolite profiling and in silico virtual screening Fatma M. Abd El-Mordy, Mohamed M. El-Hamouly, Magda T. Ibrahim, Gehad Abd El-Rheem, Omar M. Aly, Adel M. Abd El-kader, et al. (+2)
55 [GO] 2020―Aug―28 Rapid prediction of possible inhibitors for SARS-CoV-2 main protease using docking and FPL simulations Minh Quan Pham, Khanh B. Vu, T. Ngoc Han Pham, Le Thi Thuy Huong, Linh Hoang Tran, Nguyen Thanh Tung, et al. (+3)
56 [GO] 2020―Aug―25 Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets Dhivya Shanmugarajan, Prabitha P., B. R. Prashantha Kumar, B. Suresh
57 [GO] 2020―Aug―21 A density functional theory study on silver and bis-silver complexes with lighter tetrylene: are silver and bis-silver carbenes candidates for SARS-CoV-2 inhibition? Insight from molecular docking simulation Thanh Q. Bui, Huynh Thi Phuong Loan, Tran Thi Ai My, Duong Tuan Quang, Bui Thi Phuong Thuy, Vo Duy Nhan, et al. (+6)
58 [GO] 2020―Aug―13 An in silico perception for newly isolated flavonoids from peach fruit as privileged avenue for a countermeasure outbreak of COVID-19 Ahmed E. Allam, Hamdy K. Assaf, Heba Ali Hassan, Kuniyoshi Shimizu, Yaseen A. M. M. Elshaier
59 [GO] 2020―Aug―13 Understanding the role of galectin inhibitors as potential candidates for SARS-CoV-2 spike protein: in silico studies Aaftaab Sethi, Swetha Sanam, Sharon Munagalasetty, Sivaraman Jayanthi, Mallika Alvala
60 [GO] 2020―Jul―29 Targeting severe acute respiratory syndrome-coronavirus (SARS-CoV-1) with structurally diverse inhibitors: a comprehensive review Maryam S. Hosseini-Zare, Ramasamy Thilagavathi, Chelliah Selvam
61 [GO] 2020―Jul―28 A facile assay for rapid detection of COVID-19 antibodies Caixia Liu, Baiping Mao, Vanessa Martinez, Xiaojian Chen, Yanan Li, Lingyun He, et al. (+9)
62 [GO] 2020―Jul―28 An overview of key potential therapeutic strategies for combat in the COVID-19 battle Gaurav Das, Surojit Ghosh, Shubham Garg, Satyajit Ghosh, Aniket Jana, Ramkamal Samat, et al. (+3)
63 [GO] 2020―Jul―27 Potential role of medicinal plants and their constituents in the mitigation of SARS-CoV-2: identifying related therapeutic targets using network pharmacology and molecular docking analyses Eman Shawky, Ahmed A. Nada, Reham S. Ibrahim
64 [GO] 2020―Jul―17 Potential repurposed SARS-CoV-2 (COVID-19) infection drugs Gamal El-Din A. Abuo-Rahma, Mamdouh F. A. Mohamed, Tarek S. Ibrahim, Mai E. Shoman, Ebtihal Samir, Rehab M. Abd El-Baky
65 [GO] 2020―Jul―17 Remdesivir-bound and ligand-free simulations reveal the probable mechanism of inhibiting the RNA dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2 Shruti Koulgi, Vinod Jani, Mallikarjunachari V. N. Uppuladinne, Uddhavesh Sonavane, Rajendra Joshi
66 [GO] 2020―Jul―01 Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease Marisa G. Santibáñez-Morán, Edgar López-López, Fernando D. Prieto-Martínez, Norberto Sánchez-Cruz, José L. Medina-Franco
67 [GO] 2020―Jun―19 Natural products' role against COVID-19 Ananda da Silva Antonio, Larissa Silveira Moreira Wiedemann, Valdir Florêncio Veiga-Junior
68 [GO] 2020―Jun―15 Ursolic acid derivatives are potent inhibitors against porcine reproductive and respiratory syndrome virus Yang Chen, Hui Li, Li Wu, Mingxin Zhang, Yarou Gao, Heng Wang, et al. (+4)
69 [GO] 2020―May―21 Molecular docking reveals the potential of Salvadora persica flavonoids to inhibit COVID-19 virus main protease Asmaa I. Owis, Marwa S. El-Hawary, Dalia El Amir, Omar M. Aly, Usama Ramadan Abdelmohsen, Mohamed S. Kamel
70 [GO] 2020―Apr―21 Anti-HIV drug repurposing against SARS-CoV-2 Peng Sang, Shu-Hui Tian, Zhao-Hui Meng, Li-Quan Yang
71 [GO] 2020―Apr―07 High antiviral activity of mercaptoethane sulfonate functionalized Te/BSA nanostars against arterivirus and coronavirus Yanrong Zhou, Xiaohan Jiang, Ting Tong, Liurong Fang, Yuan Wu, Jiangong Liang, Shaobo Xiao


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.005 sec